136 related articles for article (PubMed ID: 36168673)
21. Evaluation of Antibodies Directed Against Two GPCRs, Anti-AT1R and Anti-ETAR, on Kidney Transplant Outcome.
El Band JEK; Llorente S; Martinez-Garcia P; Alfaro R; Jimenez-Coll V; Boix F; Galián JA; Martinez-Banaclocha H; Botella C; Moya-Quiles MR; Minguela A; Legaz I; Muro M
Curr Protein Pept Sci; 2021; 22(10):745-757. PubMed ID: 34967284
[TBL] [Abstract][Full Text] [Related]
22. Non-HLA Antibodies to G Protein-coupled Receptors in Pediatric Kidney Transplant Recipients: Short- and Long-term Clinical Outcomes.
Pearl MH; Chen L; Zuckerman JE; Weng PL; Chambers ET; Zhang Q; Reed EF
Transplantation; 2024 Jan; 108(1):276-283. PubMed ID: 37527494
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin II type 1 receptor antibodies and native kidney function in pediatric liver and intestinal transplant recipients.
Stern R; Chen L; Chan AP; Wozniak LJ; Pearl M
Pediatr Nephrol; 2023 Dec; 38(12):4175-4185. PubMed ID: 37432534
[TBL] [Abstract][Full Text] [Related]
24. Pretransplant angiotensin II type 1-receptor antibodies are a risk factor for earlier detection of de novo HLA donor-specific antibodies.
Cuevas E; Arreola-Guerra JM; Hernández-Méndez EA; Salcedo I; Castelán N; Uribe-Uribe NO; Vilatobá M; Contreras-Saldívar AG; Sánchez-Cedillo AI; Ramírez JB; de Rungs D; Granados J; Morales-Buenrostro LE; Alberú J
Nephrol Dial Transplant; 2016 Oct; 31(10):1738-45. PubMed ID: 27220757
[TBL] [Abstract][Full Text] [Related]
25. Pre-transplant Screening for Non-HLA Antibodies: Who should be Tested?
Philogene MC; Zhou S; Lonze BE; Bagnasco S; Alasfar S; Montgomery RA; Kraus E; Jackson AM; Leffell MS; Zachary AA
Hum Immunol; 2018 Apr; 79(4):195-202. PubMed ID: 29428484
[TBL] [Abstract][Full Text] [Related]
26. Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies.
Taniguchi M; Rebellato LM; Cai J; Hopfield J; Briley KP; Haisch CE; Catrou PG; Bolin P; Parker K; Kendrick WT; Kendrick SA; Harland RC; Terasaki PI
Am J Transplant; 2013 Oct; 13(10):2577-89. PubMed ID: 23941128
[TBL] [Abstract][Full Text] [Related]
27. Development of de novo HLA donor specific antibodies (HLA-DSA), HLA antibodies (HLA-Ab) and allograft rejection post blood transfusion in kidney transplant recipients.
Jalalonmuhali M; Carroll RP; Tsiopelas E; Clayton P; Coates PT
Hum Immunol; 2020 Jul; 81(7):323-329. PubMed ID: 32327243
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of Antibody against Angiotensin II Type 1 Receptor (AT1R) Among Thai Kidney Transplant Patients.
Viboon S; Townamchai N; Phiancharoen S; Kupatawintu P; Dhitivat V; Nathalang O
Transplant Proc; 2018 Jun; 50(5):1310-1315. PubMed ID: 29880351
[TBL] [Abstract][Full Text] [Related]
29. Increased negative impact of donor HLA-specific together with non-HLA-specific antibodies on graft outcome.
Reinsmoen NL; Lai CH; Mirocha J; Cao K; Ong G; Naim M; Wang Q; Haas M; Rafiei M; Czer L; Patel J; Kobashigawa J
Transplantation; 2014 Mar; 97(5):595-601. PubMed ID: 24162250
[TBL] [Abstract][Full Text] [Related]
30. Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss.
Giral M; Foucher Y; Dufay A; Duong Van Huyen JP; Renaudin K; Moreau A; Philippe A; Hegner B; Dechend R; Heidecke H; Brouard S; Cesbron A; Castagnet S; Devys A; Soulillou JP; Dragun D
Am J Transplant; 2013 Oct; 13(10):2567-76. PubMed ID: 23919486
[TBL] [Abstract][Full Text] [Related]
31. Clinical conundrums in pediatric kidney transplantation: What we know about the role of angiotensin II type I receptor antibodies in pediatric kidney transplantation and the path forward.
Pearl MH
Pediatr Transplant; 2024 May; 28(3):e14762. PubMed ID: 38650537
[TBL] [Abstract][Full Text] [Related]
32. Clinical implications of angiotensin II type 1 receptor antibodies in antibody-mediated rejection without detectable donor-specific HLA antibodies after renal transplantation.
Lee J; Park Y; Kim BS; Lee JG; Kim HJ; Kim YS; Huh KH
Transplant Proc; 2015 Apr; 47(3):649-52. PubMed ID: 25891704
[TBL] [Abstract][Full Text] [Related]
33. Angiotensin II Type-1 Receptor Antibodies Are Associated With Active Allograft Dysfunction Following Pediatric Liver Transplantation.
Wozniak LJ; Hickey MJ; Chan AP; Venick RS; Farmer DG; Busuttil RW; Reed EF; McDiarmid SV
Transplantation; 2020 Dec; 104(12):2547-2556. PubMed ID: 32101982
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin II Type 1 receptor antibodies are associated with inflammatory cytokines and poor clinical outcomes in pediatric kidney transplantation.
Pearl MH; Zhang Q; Palma Diaz MF; Grotts J; Rossetti M; Elashoff D; Gjertson DW; Weng P; Reed EF; Tsai Chambers E
Kidney Int; 2018 Jan; 93(1):260-269. PubMed ID: 28927645
[TBL] [Abstract][Full Text] [Related]
35. Is pre-transplant sensitization against angiotensin II type 1 receptor still a risk factor of graft and patient outcome in kidney transplantation in the anti-HLA Luminex era? A retrospective study.
Deltombe C; Gillaizeau F; Anglicheau D; Morelon E; Trébern-Launay K; Le Borgne F; Rimbert M; Guérif P; Malard-Castagnet S; Foucher Y; Giral M
Transpl Int; 2017 Nov; 30(11):1150-1160. PubMed ID: 28686316
[TBL] [Abstract][Full Text] [Related]
36. A 3-Center Study Reveals New Insights Into the Impact of Non-HLA Antibodies on Lung Transplantation Outcome.
Reinsmoen NL; Mirocha J; Ensor CR; Marrari M; Chaux G; Levine DJ; Zhang X; Zeevi A
Transplantation; 2017 Jun; 101(6):1215-1221. PubMed ID: 27973391
[TBL] [Abstract][Full Text] [Related]
37. Endothelin Type A Receptor Antibodies Are Associated With Angiotensin II Type 1 Receptor Antibodies, Vascular Inflammation, and Decline in Renal Function in Pediatric Kidney Transplantation.
Pearl MH; Chen L; ElChaki R; Elashoff D; Gjertson DW; Rossetti M; Weng PL; Zhang Q; Reed EF; Chambers ET
Kidney Int Rep; 2020 Nov; 5(11):1925-1936. PubMed ID: 33163713
[TBL] [Abstract][Full Text] [Related]
38. Pre-Transplant Angiotensin II Type 1 Receptor Antibodies and Anti-Endothelial Cell Antibodies Predict Graft Function and Allograft Rejection in a Low-Risk Kidney Transplantation Setting.
Yu S; Huh HJ; Lee KW; Park JB; Kim SJ; Huh W; Jang HR; Kwon GY; Moon HH; Kang ES
Ann Lab Med; 2020 Sep; 40(5):398-408. PubMed ID: 32311853
[TBL] [Abstract][Full Text] [Related]
39. Association of non-HLA antibodies against endothelial targets and donor-specific HLA antibodies with antibody-mediated rejection and graft function in pediatric kidney transplant recipients.
Fichtner A; Süsal C; Höcker B; Rieger S; Waldherr R; Westhoff JH; Sander A; Dragun D; Tönshoff B
Pediatr Nephrol; 2021 Aug; 36(8):2473-2484. PubMed ID: 33759004
[TBL] [Abstract][Full Text] [Related]
40. Effect of anti-angiotensin II type 1 receptor antibodies on the outcomes of kidney transplantation: a systematic review and meta-analysis.
Kang ZY; Liu C; Liu W; Li DH
Nephrol Dial Transplant; 2022 May; 37(6):1171-1180. PubMed ID: 34865146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
